Characterization of Wnt/β‐catenin signalling in osteoclasts in multiple myeloma

Authors:

Abstract
Summary: We recently showed that increasing Wnt/β‐catenin signalling in the bone marrow microenvironment or in multiple myeloma (MM) cells clearly suppresses osteoclastogenesis in SCID‐hu mice; however, this regulation of osteoclastogenesis could result directly from activation of Wnt/β‐catenin signalling in osteoclasts or indirectly from effects on osteoblasts. The present studies characterized Wnt/β‐catenin signalling and its potential role in osteoclasts. Systematic analysis of expression of WNT, FZD, LRP and TCF gene families demonstrated that numerous Wnt‐signalling components were expressed in human osteoclasts from patients with MM. Functional Wnt/β‐catenin signalling was identified by accumulation of total and active β‐catenin and increases in Dvl‐3 protein in response to Wnt3a or LiCl. Furthermore, Wnt‐induced increases in β‐catenin and Dvl‐3 were attenuated by Wnt antagonists Dkk1 and sFRP1. Finally, Wnt3a‐induced TCF/LEF transcriptional activity suggests that canonical Wnt signalling is active in osteoclasts. Supernatants from dominant‐negative‐β‐catenin–expressing osteoblast clones significantly stimulated tartrate‐resistant acid phosphatase–positive osteoclast formation from primary MM‐derived osteoclasts, compared with supernatants from control cells. These results suggested that Wnt/β‐catenin signalling is active in osteoclasts in MM and is involved in osteoclastogenesis in bone marrow, where it acts as a negative regulator of osteoclast formation in an osteoblast‐dependent manner in MM.

This publication has 47 references indexed in Scilit: